1. Home
  2. NWSA vs ASND Comparison

NWSA vs ASND Comparison

Compare NWSA & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo News Corporation

NWSA

News Corporation

HOLD

Current Price

$26.18

Market Cap

14.6B

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$219.52

Market Cap

14.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWSA
ASND
Founded
2012
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6B
14.7B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
NWSA
ASND
Price
$26.18
$219.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
16
Target Price
$38.18
$281.50
AVG Volume (30 Days)
4.2M
711.2K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
0.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.06
$96.35
Revenue Next Year
$3.25
$44.91
P/E Ratio
$11.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.20
$151.11
52 Week High
$31.61
$250.74

Technical Indicators

Market Signals
Indicator
NWSA
ASND
Relative Strength Index (RSI) 63.40 38.88
Support Level $25.80 $214.92
Resistance Level $27.01 $224.96
Average True Range (ATR) 0.54 7.50
MACD 0.05 -2.61
Stochastic Oscillator 74.75 8.15

Price Performance

Historical Comparison
NWSA
ASND

About NWSA News Corporation

News Corporation is a diversified media conglomerate with large presence in the US, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. Its 61%-owned REA Group is the dominant property listings platform in Australia. In addition, it owns Harper Collins, one of the largest book publishers in the world, and has a sizable US digital property advertising business, Move. The 65% interest in Foxtel, the Australian pay-TV and streaming provider, was sold in April 2025. The sale to global sports streaming platform, DAZN, was struck at more than 7 times Foxtel's EBITDA.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: